The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014
Open accessAbstract
The incidence rates of thin melanomas (≤1 mm Breslow thickness) have increased in many fair-skinned populations, prompting a need to better identify patients with thin melanomas who will eventually die from the disease. This study aimed to describe the clinicopathological characteristics of lethal melanomas in Western Sweden, with a focus on thin lesions. Population-based data on invasive melanomas diagnosed during the years 1990 to 2014 were extracted from the Swedish Melanoma Registry, and linked to the Swedish Cause of Death Registry. The age-standardized incidence (US population 2000) of thin melanomas increased from 9.1×10-5 (95% confidence interval (95% CI) 8.5-9.8) to 21.3×10-5 (95% CI 20.4-22.1) during the study period. Thin melanomas comprised 55.2% of the total and contributed to 13.5% of all melanoma deaths. Non-ulcerated melanomas 0.76-1 mm and ulcerated melanomas 0.26-1.0 mm showed a poorer survival compared with other thin melanomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,653
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Balch, C. M., Soong, S., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M. M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,383
Whiteman, D. C., Green, A. C., & Olsen, C. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.035 · Cited by 650
Self-citationTrends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002
Coory, M. D., Baade, P. D., Aitken, J. F., Smithers, B. M., McLeod, G. R., & Ring, I. T. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-3637-4 · Cited by 230
Green, A. C., Baade, P. D., Coory, M. D., Aitken, J. F., & Smithers, B. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8561 · Cited by 207
Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas
Gimotty, P. A., Elder, D. E., Fraker, D. L., Botbyl, J. D., Sellers, K. F., Elenitsas, R., Ming, M. E., Schuchter, L. M., Spitz, F. R., Czerniecki, B. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1463 · Cited by 206
Leiter, U., Buettner, P. G., Eigentler, T., & Garbe, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.074 · Cited by 127
Balch, C. M., Gershenwald, J. E., Soong, S., & Thompson, J. F. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21876 · Cited by 124
Invasive cutaneous malignant melanoma in Sweden, 1990–1999
Lindholm, C., Andersson, R., Dufmats, M., Hansson, J., Ingvar, C., Möller, T., Sjödin, H., Stierner, U. K., Wagenius, G., & for the Swedish Melanoma Study Group (2004) · Cancer · doi:10.1002/cncr.20602 · Cited by 108
Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006
Baade, P. D., Meng, X., Youlden, D. R., Aitken, J. F., & Youl, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25996 · Cited by 91
A Population-Based Validation of the American Joint Committee on Cancer Melanoma Staging System
Gimotty, P. A., Botbyl, J. D., Soong, S., & Guerry, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4976 · Cited by 90
Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review
Måsbäck, A., Olsson, H. L., Westerdahl, J., Ingvar, C., & Jonsson, N. (2001) · Melanoma Research · doi:10.1097/00008390-200110000-00001 · Cited by 85
Melanoma epidemic: Facts and controversies
Erickson, C., & Driscoll, M. S. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2009.06.021 · Cited by 62
Lyth, J., Hansson, J., Ingvar, C., Månsson‐Brahme, E., Naredi, P. L. J., Stierner, U. K., Wagenius, G., Lindholm, C., & for the Swedish Melanoma Study Group (2012) · British Journal of Dermatology · doi:10.1111/bjd.12095 · Cited by 50
de Vries, E., Bray, F., Eggermont, A. M. M., & Coebergh, J. W. W. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200410000-00006 · Cited by 48
Lyth, J., Eriksson, H., Hansson, J., Ingvar, C., Jansson, M., Lapins, J., Månsson‐Brahme, E., Naredi, P. L. J., Stierner, U. K., Ullenhag, G. J., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13483 · Cited by 39
Malignant Melanoma of the Skin: Long‐term Follow‐up and Time to First Recurrence
Hohnheiser, A. M., Gefeller, O., Göhl, J., Schuler, G., Hohenberger, W., & Merkel, S. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0859-8 · Cited by 37
(2005) · Van Nostrand's Scientific Encyclopedia · doi:10.1002/0471743984.vse5707 · Cited by 35
Melanoma burden by melanoma stage: Assessment through a disease transition model
Tromme, I., Legrand, C., Devleesschauwer, B., Leiter, U., Suciu, S., Eggermont, A. M. M., Francart, J., Calay, F., Haagsma, J. A., Baurain, J., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.016 · Cited by 25
Incidence of cutaneous melanoma in Western Sweden, 1970–2007
Claeson, M., Andersson, E. M., Wallin, M., Wastensson, G., Wennberg, A., Paoli, J., & Gonzalez, H. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e32835861d6 · Cited by 11
Self-citationModelling the Future: System Dynamics in the Cutaneous Malignant Melanoma Care Pathway
Claeson, M., Hallberg, S., Holmström, P., Wennberg, A., Gonzalez, H., & Paoli, J. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2222 · Cited by 9
Self-citationIdentification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas
Lang, P. G. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70966-3 · Cited by 6
Flagged first, then by citations
1 of the 24 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Whiteman DC, Baade PD, Olsen CM. More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest Dermatol 2015; 135: 1190-1193.
- Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev 2015; 24: 141-149.
- McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survi- val data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 2003; 98: 1223-1231.
- Elder DE. Thin melanoma. Arch Pathol Lab Med 2011; 135: 342-346.
Cited by
Sorted by citations
Multimodal skin lesion classification using deep learning
Yap, J., Yolland, W., & Tschandl, P. (2018) · Experimental Dermatology · doi:10.1111/exd.13777 · Cited by 326
Five-year survival in patients with nodular and superficial spreading melanomas in the US population
Allais, B. S., Beatson, M., Wang, H., Shahbazi, S., Bijelić, L., Jang, S., & Venna, S. S. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.11.047 · Cited by 47
Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma
Claeson, M., Baade, P. D., Brown, S., Soyer, H. P., Smithers, B. M., Green, A. C., Whiteman, D. C., & Khosrotehrani, K. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18560 · Cited by 29
Self-citationWennberg, E., Claeson, M., Bagge, R. O., Polesie, S., & Paoli, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094544 · Cited by 7
Self-citationMelanoma Prevention and Screening
Swetter, S. M., Geller, A. C., Leachman, S. A., Kirkwood, J. M., Katalinic, A., & Gershenwald, J. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_6 · Cited by 5
Manneschi, G., Caldarella, A., Caini, S., Checchi, S., Intrieri, T., Chiarugi, A., Nardini, P., & Masala, G. (2024) · Cancers · doi:10.3390/cancers16030536 · Cited by 3
“Of note, studies conducted in Australia [12], Sweden [6], Denmark [17], and the USA [11] have reported largely similar results, despite the fact that the most important characteristics affecting melanoma epidemiology, namely phototype and habits of exposure to sunlight and artificial UV radiation,…”
BackgroundResultInfluentialMelanoma Prevention and Screening
Swetter, S. M., Geller, A. C., Leachman, S. A., Kirkwood, J. M., Katalinic, A., & Gershenwald, J. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-46029-1_6-1 · Cited by 2
Strömberg, U., Claeson, M., & Paoli, J. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1616817 · Cited by 1
“Besides, a steadily increasing time trend in the age-standardised incidence of thin CMM has been reported [5].”
BackgroundSelf-citationGillstedt, M., Stempfle, L., Paoli, J., Johansson, F., & Polesie, S. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.44610
Self-citation
Metadata
- Authors
- Claeson, M., Gillstedt, M., Whiteman, D., & Paoli, J.
- Affiliations
- University of Gothenburg (SE)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Claeson, M
- Venue
- Acta Dermato Venereologica
- Published
- 2017
- Volume
- 97
- Issue
- 10
- Pages
- 1206-1211
- ISSN
- 0001-5555 (ISSN-L)
- OpenAlex
- W2741691238
- Cited by
- 9
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2020: 2 · 2019: 2 · 2018: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Dermato Venereologica (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Australian Government
- HudFonden
- Medical Research Council
- National Health and Medical Research Council (1058522)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- thin melanoma, melanoma mortality, melanoma incidence, Breslow thickness, ulcerated melanoma, survival, clinicopathological features, Western Sweden
- MeSH terms
- Adult, Aged, Female, Humans, Male, Melanoma, Middle Aged, Neoplasm Staging, Prognosis, Registries, Risk Factors, Skin Neoplasms, Sweden, Time Factors, Incidence, Proportional Hazards Models, Age Distribution, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
